Man Group
ACHN

Man Group’s Achillion Pharmaceuticals ACHN Stock Holding History

Man Group’s Portfolio ACHN Stock Details ACHN Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2019
Q4 		– Sell
-195,340
Closed -$703K – 1976
2019
Q3 		$703K Sell
195,340
-481,619
-71% -$1.86M ﹤0.01% 1509
2019
Q2 		$1.81M Sell
676,959
-500
-0.1% -$1.48K 0.01% 1339
2019
Q1 		$2M Sell
677,459
-760,654
-53% -$1.87M 0.01% 1333
2018
Q4 		$2.29M Sell
1,438,113
-53,651
-4% -$152K 0.01% 1153
2018
Q3 		$5.49M Sell
1,491,764
-500
-0% -$1.49K 0.02% 933
2018
Q2 		$4.22M Sell
1,492,264
-63,900
-4% -$218K 0.02% 1028
2018
Q1 		$5.77M Buy
+1,556,164
New +$5.09M 0.03% 769

Other funds holding ACHN

Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
Dimensional Fund Advisors
Dimensional Fund Advisors Austin, Texas $481B AUM 30.42% 1-Year Est. Return
VI
Versor Investments New York $40.8M AUM 93.59% 1-Year Est. Return
PCM
Pentwater Capital Management Naples, Florida $19.3B AUM 58.13% 1-Year Est. Return
RI
RTW Investments New York $10B AUM 135.35% 1-Year Est. Return
MCO
MAK Capital One New York $679M AUM 29.02% 1-Year Est. Return
MF
Magnetar Financial Evanston, Illinois $9.84B AUM 190.64% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
Renaissance Technologies
Renaissance Technologies New York $63.9B AUM 45.56% 1-Year Est. Return

Man Group's ACHN Position: Q4 2019 in Review

Man Group sold out of Achillion Pharmaceuticals (ACHN) in Q4 2019, closing a stake of 195,340 shares — an estimated $703K sold.

Man Group first reported a position in ACHN in Q1 2018 and held it in 7 quarters. The position peaked at $5.77M in Q1 2018. 132 funds tracked by Wall St. Rank hold ACHN as of Q4 2019.

  • Man Group reported no remaining Achillion Pharmaceuticals position as of Q4 2019 after selling out during the quarter.
  • Man Group sold 195,340 Achillion Pharmaceuticals shares in Q4 2019, an estimated $703K.
  • Man Group first reported a position in Achillion Pharmaceuticals in Q1 2018 and held it in 7 quarters.
  • Man Group's Achillion Pharmaceuticals position peaked at $5.77M in Q1 2018.
  • 132 funds tracked by Wall St. Rank held Achillion Pharmaceuticals as of Q4 2019.

Based on Man Group's 13F filing for Q4 2019, filed 18 Feb 2020.